New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Non-tuberculous mycobacterial (NTM) infections are caused by bacteria found in the environment. In healthy individuals, these bacteria normally cause no harm. However, for those who have a compromised immune system or who…

Continue Reading New Phase 1 Clinical Trial for Potential Oral Medication for Non-Tuberculous Mycobacterial (NTM) Infections

Don’t Miss The Final Screening of “Take A Look At This Heart,” About Love and Intimacy in the Disabled Community

A rarely addressed subject that comes up in discussions about people with disabilities is the subject of romantic relationships, intimacy, and parenting. More than likely, a lot of day to…

Continue Reading Don’t Miss The Final Screening of “Take A Look At This Heart,” About Love and Intimacy in the Disabled Community
After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
AndCan / Pixabay

After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia

According to a story from wired.com, everything changed for Sonia Vallabh and her husband Eric Minikel after Sonia's mother died from a mysterious illness. Sonia's mother Kamni was in her…

Continue Reading After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
source: pixabay.com

Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit

Notable Labs Notable Labs was created after founder, Matt De Silva, felt he was left in a helpless point, following a year of research on treatment options for his father's Glioblastoma…

Continue Reading Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
qimono / Pixabay

Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

According to a story from statnews.com, the biotechnology company Alexion Pharmaceuticals recently announced that its product Ultomiris, which was recently approved as a treatment for paroxysmal nocturnal hemoglobinuria, was also…

Continue Reading Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
source: pixabay.com

Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients

The most common treatment for someone who is discovered to have early stage kidney cancer is surgery. The patient's tumors and a part of their kidneys are removed through a…

Continue Reading Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
Doctor With Idiopathic Multicentric Castleman Disease Continues to Make Progress in Researching His Own Disease
rawpixel / Pixabay

Doctor With Idiopathic Multicentric Castleman Disease Continues to Make Progress in Researching His Own Disease

According to a story from the Philly Voice, it has been nearly nine years since Dr. David Fajgenbaum was first diagnosed with idiopathic multicentric Castleman disease. This immune system disorder…

Continue Reading Doctor With Idiopathic Multicentric Castleman Disease Continues to Make Progress in Researching His Own Disease